PARP1 UFMylation ensures the stability of stalled replication forks
Proceedings of the National Academy of Sciences · 30.04.2024 · 121 (18)
DOI: 10.1073/pnas.2322520121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 24.04.2024. Verfasst von Yamin Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University School of Medicine, Shenzhen, Guangdong 518060, China. Hauptthemen laut MEDLINE: DNA Replication, Poly (ADP-Ribose) Polymerase-1, Checkpoint Kinase 1. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | NSFC | Key Programme.
Abstract (Originalsprache)
The S-phase checkpoint involving CHK1 is essential for fork stability in response to fork stalling. PARP1 acts as a sensor of replication stress and is required for CHK1 activation. However, it is unclear how the activity of PARP1 is regulated. Here, we found that UFMylation is required for the efficient activation of CHK1 by UFMylating PARP1 at K548 during replication stress. Inactivation of UFL1, the E3 enzyme essential for UFMylation, delayed CHK1 activation and inhibits nascent DNA degradation during replication blockage as seen in PARP1-deficient cells. An in vitro study indicated that PARP1 is UFMylated at K548, which enhances its catalytic activity. Correspondingly, a PARP1 UFMylation-deficient mutant (K548R) and pathogenic mutant (F553L) compromised CHK1 activation, the restart of stalled replication forks following replication blockage, and chromosome stability. Defective PARP1 UFMylation also resulted in excessive nascent DNA degradation at stalled replication forks. Finally, we observed that PARP1 UFMylation-deficient knock-in mice exhibited increased sensitivity to replication stress caused by anticancer treatments. Thus, we demonstrate that PARP1 UFMylation promotes CHK1 activation and replication fork stability during replication stress, thus safeguarding genome integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University School of Medicine, Shenzhen, Guangdong 518060, China.
- Leibniz Institute on Aging-Fritz Lipmann Institute, Jena 07745, Germany.
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
- Faculty of Biology and Pharmacy, Friedrich-Schiller University of Jena, Jena 07743, Germany.
ORCID-Profile: Zhifeng Wang, Wen Zong, Bin Peng
Förderung
- MOST | NSFC | Key Programme
Zitieren
APA
Gong, Y., Wang, Z., Zong, W., Shi, R., Sun, W., Wang, S., Peng, B., Takeda, S., Wang, Z. Q., & Xu, X. (2024). PARP1 UFMylation ensures the stability of stalled replication forks. Proceedings of the National Academy of Sciences, 121(18). https://doi.org/10.1073/pnas.2322520121
Vancouver
Gong Y, Wang Z, Zong W, Shi R, Sun W, Wang S, et al. PARP1 UFMylation ensures the stability of stalled replication forks. Proceedings of the National Academy of Sciences. 2024;121(18). doi:10.1073/pnas.2322520121
BibTeX
@article{Gong2024,
author = {Gong, Yamin and Wang, Zhifeng and Zong, Wen and Shi, Ruifeng and Sun, Wenli and Wang, Sijia and Peng, Bin and Takeda, Shunichi and Wang, Zhao-Qi and Xu, Xingzhi},
title = {PARP1 UFMylation ensures the stability of stalled replication forks},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {18},
doi = {10.1073/pnas.2322520121}
}
EUVIMED